Chronic Liver Disease
Clinical Care and Management (CCM)
Filter By:
Start-up
CTN 326: LIVEHIV Cohort Plus
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
Learn MoreStart-up
CTN 331: DDI Study: Drug-drug interactions between ART and feminizing hormones in trans women living with HIV
Drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV
Learn MoreStart-up
CTN 330: Predicting and evaluating anal cancer in HIV with novel biomarkers (The PEACH Study)
Development and validation of an anal cancer screening algorithm in HIV-positive men who have sex with men
Learn MoreEnrolling
CTN 313: The DaDHS Trial
A randomized, placebo-controlled trial of oral doxycycline for the prevention of syphilis in HIV-positive men who have sex with men (MSM)
Learn MoreEnrolling
CTN 325: Optimising Outcomes in the Cascade of HIV Care
Optimising Outcomes at Critical Points in the Cascade of HIV Care in Ontario
Learn MoreEnrolling
CTN 328: COVID-19 Vaccine in HIV
Immunogenicity outcomes in people living with HIV following vaccination for COVID-19 (HIV-COV)
Learn MoreEnrolling
CTN 327: Impact of COVID-19 on persons with HIV in Canada
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
Learn MoreEnrolling
CTNPT 039: The I-Score/Opal Implementation Pilot Study
Electronic capture through the Opal patient portal of a patient-reported measure of barriers to antiretroviral therapy adherence: a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.